These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22415583)

  • 1. Increased urinary podocytes following indomethacin suggests drug-induced glomerular injury.
    Kent AL; Brown L; Broom M; Broomfield A; Dahlstrom JE
    Pediatr Nephrol; 2012 Jul; 27(7):1111-7. PubMed ID: 22415583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing urinary podocyte mRNA excretion and progressive podocyte loss in kidney contribute to the high risk of long-term renal disease caused by preterm birth.
    Ding F; Gao Q; Tian X; Mo J; Zheng J
    Sci Rep; 2021 Oct; 11(1):20650. PubMed ID: 34667204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indomethacin responsiveness of patent ductus arteriosus and renal abnormalities in preterm infants treated with indomethacin.
    Itabashi K; Ohno T; Nishida H
    J Pediatr; 2003 Aug; 143(2):203-7. PubMed ID: 12970633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus.
    Andriessen P; Struis NC; Niemarkt H; Oetomo SB; Tanke RB; Van Overmeire B
    Acta Paediatr; 2009 May; 98(5):797-803. PubMed ID: 19187396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furosemide does not prevent indomethacin-induced renal side effects in preterm infants.
    Romagnoli C; Zecca E; Papacci P; De Carolis MP; Giannini R; Gallini F; Tortorolo G
    Clin Pharmacol Ther; 1997 Aug; 62(2):181-6. PubMed ID: 9284854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary acute kidney injury biomarkers in very low-birth-weight infants on indomethacin for patent ductus arteriosus.
    Waldherr S; Fichtner A; Beedgen B; Bruckner T; Schaefer F; Tönshoff B; Pöschl J; Westhoff TH; Westhoff JH
    Pediatr Res; 2019 Apr; 85(5):678-686. PubMed ID: 30745571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal effective dose of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Dumas de la Roque E; Fayon M; Babre F; Demarquez JL; Pedespan L
    Biol Neonate; 2002; 81(2):91-4. PubMed ID: 11844876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.
    Pacifici GM
    Curr Pediatr Rev; 2014; 10(3):216-37. PubMed ID: 25088343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of gentamicin on glomerular and tubular functions in preterm neonates.
    Tugay S; Bircan Z; Cağlayan C; Arisoy AE; Gökalp AS
    Pediatr Nephrol; 2006 Oct; 21(10):1389-92. PubMed ID: 16897006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furosemide prevents the renal side effects of indomethacin therapy in premature infants with patent ductus arteriosus.
    Yeh TF; Wilks A; Singh J; Betkerur M; Lilien L; Pildes RS
    J Pediatr; 1982 Sep; 101(3):433-7. PubMed ID: 7108667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing sulindac with indomethacin for closure of ductus arteriosus in preterm infants.
    Ng PC; So KW; Fok TF; Yam MC; Wong MY; Wong W
    J Paediatr Child Health; 1997 Aug; 33(4):324-8. PubMed ID: 9323621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates--is postnatal age at start of treatment important?
    Srinivasjois RM; Nathan EA; Doherty DA; Patole SK
    J Matern Fetal Neonatal Med; 2006 Dec; 19(12):793-9. PubMed ID: 17190690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indomethacin and renal impairment in neonates.
    Akima S; Kent A; Reynolds GJ; Gallagher M; Falk MC
    Pediatr Nephrol; 2004 May; 19(5):490-3. PubMed ID: 15007713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indomethacin for preterm infants with intracranial hemorrhage.
    Chiba H; Masutani S; Toyoshima K; Mori R
    Pediatr Int; 2013 Feb; 55(1):124-6. PubMed ID: 23409994
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent ductus arteriosus, indomethacin and necrotizing enterocolitis in very low birth weight infants: a population-based study.
    Dollberg S; Lusky A; Reichman B
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):184-8. PubMed ID: 15699694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants.
    Su PH; Chen JY; Su CM; Huang TC; Lee HS
    Pediatr Int; 2003 Dec; 45(6):665-70. PubMed ID: 14651538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indomethacin and its effect on renal function and urinary kallikrein excretion in premature infants with patent ductus arteriosus.
    Betkerur MV; Yeh TF; Miller K; Glasser RJ; Pildes RS
    Pediatrics; 1981 Jul; 68(1):99-102. PubMed ID: 6909683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal glomeruli and tubular injury following indomethacin, ibuprofen, and gentamicin exposure in a neonatal rat model.
    Kent AL; Maxwell LE; Koina ME; Falk MC; Willenborg D; Dahlstrom JE
    Pediatr Res; 2007 Sep; 62(3):307-12. PubMed ID: 17622959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.